Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.780
+0.020 (1.14%)
At close: Oct 30, 2025, 4:00 PM EDT
1.690
-0.090 (-5.06%)
Pre-market: Oct 31, 2025, 4:18 AM EDT
Ernexa Therapeutics Employees
Ernexa Therapeutics had 6 employees as of December 31, 2024. The number of employees decreased by 2 or -25.00% compared to the previous year.
Employees
6
Change (1Y)
-2
Growth (1Y)
-25.00%
Revenue / Employee
$81,333
Profits / Employee
-$7,286,667
Market Cap
13.65M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6 | -2 | -25.00% |
| Dec 31, 2023 | 8 | -1 | -11.11% |
| Dec 31, 2022 | 9 | -1 | -10.00% |
| Dec 31, 2021 | 10 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ERNA News
- 1 day ago - Cellipont Bioservices and Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership to Advance ERNA-101 Toward Clinical Trials in Ovarian Cancer - PRNewsWire
- 4 weeks ago - Ernexa Therapeutics to Deliver Company Presentation at the Annual Cell & Gene Meeting on the Mesa - GlobeNewsWire
- 4 weeks ago - Ernexa Therapeutics President & CEO Sanjeev Luther to Present on Expert Panel at 5th Annual iPSC Drug Development Summit - GlobeNewsWire
- 6 weeks ago - Ernexa Therapeutics to Present New Data in Oral Presentation at AACR Special Conference in Cancer Research - GlobeNewsWire
- 7 weeks ago - Ernexa Therapeutics Provides Update on Operational Excellence and Performance - GlobeNewsWire
- 2 months ago - Ernexa Therapeutics Announces Presentation At The H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Ernexa Therapeutics Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 4 months ago - Ernexa Therapeutics Expands Advisory Board to Form Integrated Scientific and Medical Advisory Board as it Prepares for Clinical Development - GlobeNewsWire